Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 EUR | +5.77% |
|
+0.46% | +88.03% |
Jun. 27 | Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024 | CI |
Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
Sales 2024 * | 51.18M 55.75M | Sales 2025 * | 59.29M 64.59M | Capitalization | 72.64M 79.13M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.09M | Net income 2025 * | 4M 4.36M | EV / Sales 2024 * | 1.23 x |
Net cash position 2024 * | 9.63M 10.49M | Net cash position 2025 * | 10.19M 11.1M | EV / Sales 2025 * | 1.05 x |
P/E ratio 2024 * |
58.1
x | P/E ratio 2025 * |
18.6
x | Employees | 177 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Apontis Pharma AG
1 day | +5.77% | ||
1 week | +0.46% | ||
Current month | +5.77% | ||
1 month | +11.39% | ||
3 months | +2.80% | ||
6 months | +110.02% | ||
Current year | +88.03% |
![Extreme 8.32](/images/extremecours_fleche.png)
![Extreme 7.96](/images/extremecours_fleche.png)
![Extreme 4](/images/extremecours_fleche.png)
![Extreme 2.82](/images/extremecours_fleche.png)
![Extreme 2.82](/images/extremecours_fleche.png)
![Extreme 2.82](/images/extremecours_fleche.png)
![Extreme 2.82](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Director of Finance/CFO | - | 21-12-31 | |
Olaf Randerath
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edin Hadzic
BRD | Director/Board Member | 54 | 20-12-31 |
Olaf Elbracht
BRD | Director/Board Member | 59 | 20-12-31 |
Chairman | 51 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-15 | 8.8 | +5.77% | 50 |
24-07-12 | 8.32 | -1.42% | 0 |
24-07-11 | 8.44 | +0.24% | 0 |
24-07-10 | 8.42 | -1.41% | 0 |
24-07-09 | 8.54 | -2.51% | 0 |
Delayed Quote Deutsche Boerse AG, July 15, 2024 at 10:00 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+8.43% | 301B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B |
- Stock Market
- Equities
- APPH Stock
- APPH Stock